WELLS FARGO & COMPANY/MN - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 143 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2016. The put-call ratio across all filers is 1.43 and the average weighting 0.0%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2019$456,000
+26.7%
98,679
-4.1%
0.00%
Q4 2018$360,000
-53.7%
102,920
+33.5%
0.00%
Q3 2018$778,000
+88.4%
77,101
+35.3%
0.00%
Q2 2018$413,000
+25.5%
57,001
+4.7%
0.00%
Q1 2018$329,000
-40.1%
54,464
-4.5%
0.00%
Q4 2017$549,000
+49.2%
57,020
+37.3%
0.00%
Q3 2017$368,000
+5.1%
41,516
+50.1%
0.00%
Q2 2017$350,000
+21.1%
27,667
+0.5%
0.00%
Q1 2017$289,000
+48.2%
27,541
+30.3%
0.00%
Q4 2016$195,000
-24.7%
21,134
-3.9%
0.00%
Q3 2016$259,000
-14.2%
21,985
-5.9%
0.00%
Q2 2016$302,000
-26.9%
23,362
-9.6%
0.00%
Q1 2016$413,000
-46.4%
25,829
-3.9%
0.00%
Q4 2015$770,000
-96.8%
26,878
-96.8%
0.00%
-100.0%
Q3 2015$23,893,000
+359.7%
839,525
+480.3%
0.01%
+400.0%
Q2 2015$5,197,000
-72.1%
144,661
-54.8%
0.00%
-50.0%
Q1 2015$18,606,000
+152.2%
320,134
+83.0%
0.00%
+33.3%
Q4 2014$7,377,000
+68.9%
174,953
+55.3%
0.00%
+50.0%
Q3 2014$4,368,000
+42.0%
112,637
+14.3%
0.00%
+100.0%
Q2 2014$3,077,000
-34.3%
98,519
-12.8%
0.00%
-50.0%
Q1 2014$4,681,000
+82.2%
112,993
+70.2%
0.00%
+100.0%
Q4 2013$2,569,000
-29.6%
66,381
-36.3%
0.00%
-50.0%
Q3 2013$3,648,000
+13.5%
104,247
-55.1%
0.00%0.0%
Q2 2013$3,213,000232,1880.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2016
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$00.00%
View complete list of INSYS THERAPEUTICS INC NEW shareholders